SCHEMBL2299608

SCHEMBL2299608

O=C1NCCN1c1ccc(S(=O)(=O)O)c(-c2cc(F)cc(F)c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.39
TDO2 P48775 2/20 0.35
ALDH1A1 P00352 2/20 0.34
POLB P06746 1/20 0.34
EIF2AK2 P19525 1/20 0.34
HCRTR1 O43613 1/20 0.32
NPY5R Q15761 1/20 0.32
CCNA2 P20248 3/20 0.32
CDK2 P24941 3/20 0.32
CCNA1 P78396 3/20 0.32
ALOX5AP P20292 2/20 0.32
FEN1 P39748 2/20 0.32
BACE1 P56817 1/20 0.32
ELANE P08246 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
PER2 O15055 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2306298 0.90 TDO2 (0.39) ALOX5TDO2ALDH1A1POLBEIF2AK2
SCHEMBL2307068 0.90 TDO2 (0.40) TDO2ALDH1A1POLBEIF2AK2ALOX5AP
SCHEMBL2299338 0.89 HCRTR1 (0.39) ALOX5TDO2EIF2AK2HCRTR1ALOX5AP
SCHEMBL2299702 0.87 ALOX5AP (0.38) TDO2HCRTR1ALOX5APFEN1
SCHEMBL2301831 0.86 MEN1 (0.36) ALOX5EIF2AK2CCNA2CDK2CCNA1
SCHEMBL2304343 0.86 CCNA2 (0.33) ALOX5TDO2ALDH1A1POLBEIF2AK2
SCHEMBL2303927 0.86 EIF2AK2 (0.43) ALOX5ALDH1A1EIF2AK2CCNA2CDK2
SCHEMBL2304872 0.85 KMT2A (0.38) TDO2ALDH1A1EIF2AK2CCNA2CDK2
SCHEMBL2302623 0.85 ALDH1A1 (0.34) ALOX5TDO2ALDH1A1POLBEIF2AK2
SCHEMBL2300754 0.85 ALDH1A1 (0.35) TDO2ALDH1A1EIF2AK2CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034888-B2 Substituted 2-imidazolidones and analogs UNIVERSITE LAVAL (CA) 2015-05-19 US disclosed
EP-2536693-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS Université Laval (CA) 2012-12-26 EP disclosed
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITE LAVAL (CA) 2012-12-06 US disclosed
WO-2011100840-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITé LAVAL (CA) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS CCNY, RPS4Y1, TPX2 ALOX5 4821/4885TDO2 3925/4885ALDH1A1 1937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.